opc 14117 has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chase, TN; Nakai, M; Qin, Z; Wang, Y | 1 |
2 other study(ies) available for opc 14117 and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
OPC 14117.
Topics: Animals; Antioxidants; Brain Ischemia; Drugs, Investigational; Humans; Indans; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Piperazines; Rats | 1999 |
NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117.
Topics: Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Central Nervous System Depressants; Corpus Striatum; Cysteine Proteinase Inhibitors; DNA Fragmentation; Ethanol; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Indans; Kainic Acid; Male; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; NF-kappa B; Oligopeptides; Piperazines; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Transcription Factor AP-1 | 2000 |